Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease

for the GS-US-321-0102 Investigators

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Fingerprint Dive into the research topics of 'Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease'. Together they form a unique fingerprint.

Medicine & Life Sciences